![Takashi Matsumoto](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Takashi Matsumoto
Directeur/Membre du Conseil chez DAIICHI SANKYO COMPANY, LIMITED
Provenance du réseau au premier degré de Takashi Matsumoto
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 72 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Takashi Matsumoto via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
University of Tokyo | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Keio University | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| AJINOMOTO CO., INC. | Food: Specialty/Candy | Director/Board Member Chief Executive Officer | |
| JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | President Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Kitasato Daiichi Sankyo Vaccine Co., Ltd. develops, manufactures and distributes vaccines. The company is based in Kitamoto, Japan. Kitasato Daiichi Sankyo Vaccine Co. was acquired by Daiichi Sankyo Co., Ltd. from The Kitasato Institute on November 30, 2017. | Pharmaceuticals: Major | President President | |
Doshisha University | College/University | Undergraduate Degree | |
The Consumer Goods Forum
 The Consumer Goods Forum Miscellaneous Commercial ServicesCommercial Services The Consumer Goods Forum operates as a business association. The company was founded in and is headquartered in Issy-les-Moulineaux, France. | Miscellaneous Commercial Services | Director/Board Member | |
Nippon Venture Capital Corp.
 Nippon Venture Capital Corp. Investment ManagersFinance Nippon Venture Capital Corp. (NVCC) is an independent venture capital firm founded in 1996. The firm is headquartered in Tokyo, Japan. | Investment Managers | Director/Board Member | |
| KAO CORPORATION | Household/Personal Care | Director/Board Member | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | President | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded by Robert Wood Johnson II in 1972 and is dedicated solely to health. RWJF funds offers a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | President | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a gene coding private company that uses exact DNA integration technology to develop durable, safe, and accessible genetic medicines for genetic diseases. The company is based in Lexington, MA. The company focuses on one-time treatments for Stargardt disease and cystic fibrosis, and is also developing its technology for other inherited retinal diseases and to engineer CAR-T cells for cancer and autoimmune conditions. The company was founded by Joseph J. Higgins. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical-stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company's mission is to confront the challenges of treating complex diseases by advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Jaguar Gene Therapy is made up of a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. The company's lead program focuses on severe neurodevelopmental disorders caused by shank3 haploinsufficiency, including a genetic form of autism spectrum disorder and phelan-mcdermid syndrome. The company also has pipeline programs targeting type 1 galactosemia and type 1 diabetes. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal | |
Daiichi Sankyo Biotech Co. Ltd.
 Daiichi Sankyo Biotech Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Daiichi Sankyo Biotech Co. Ltd. is a Japanese company focused on the stable supply of vaccines and the manufacturing of biopharmaceuticals. The company is located in Japan. The company aims to contribute to the improvement and acceleration of biopharmaceutical development. | Pharmaceuticals: Major | Chairman | |
NTT Data
 NTT Data Information Technology ServicesTechnology Services Everis Spain SL provides information technology, business process outsourcing, and consulting services. Its service portfolio includes bigdata, business process outsourcing, business consulting, and everismart. The firm serves the aerospace and defense, banking, distribution and retail, health, insurance, logistics and transport, manufacturing, and utilities and energy industry. The company was founded in 1996 and is headquartered in Madrid, Spain. | Information Technology Services | Chief Executive Officer | |
| JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
Nippon Wellcome Kk
 Nippon Wellcome Kk Pharmaceuticals: OtherHealth Technology Part of GSK Plc, Nippon Wellcome Kk is a Japanese company that researches, develops, manufactures, and markets pharmaceuticals. The company is located in Japan. Nippon Wellcome Kk was acquired by Glaxo Wellcome Plc on April 01, 1999. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Sanofi-Aventis Ltd.
 Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NTT DATA GROUP CORPORATION | Information Technology Services | Chief Executive Officer | |
Construction-ec.com Co., Ltd.
 Construction-ec.com Co., Ltd. Catalog/Specialty DistributionRetail Trade Construction-ec.com Co., Ltd. is a Japanese company that has been providing electronic contract services for 20 years. The private company is based in Tokyo, Japan. The company offers various electronic document exchange services, including electronic signature services such as CECTRUST-Light and Docusign. The company also provides cloud services for electronic commercial transactions, such as CIWEB, which supports the industry standard recommended by the Ministry of Land, Infrastructure, Transport and Tourism. The company aims to digitize commercial transactions to improve work efficiency and reduce costs. | Catalog/Specialty Distribution | President | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin | |
University of Hitotsubashi | College/University | Undergraduate Degree | |
Osaka University | College/University | Graduate Degree | |
Tokyo Medical & Dental University | College/University | Doctorate Degree | |
| SONY GROUP CORPORATION | Computer Processing Hardware | Director/Board Member | |
| HISAMITSU PHARMACEUTICAL CO., INC. | Pharmaceuticals: Major | Director/Board Member | |
| ZACROS CORPORATION | Industrial Specialties | Director/Board Member | |
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
Stony Brook University | College/University | Undergraduate Degree | |
University of Connecticut | College/University | Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 22 |
| Japon | 21 |
| Suisse | 3 |
| France | 3 |
| Royaume-Uni | 3 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 13 |
| Finance | 6 |
| Health Services | 4 |
| Consumer Non-Durables | 3 |
Opérationnelle
| Director/Board Member | 119 |
| Corporate Officer/Principal | 59 |
| Independent Dir/Board Member | 38 |
| Chairman | 26 |
| President | 20 |
Relations les plus connectées
| Insiders | |
|---|---|
| Sawako Nohara | 15 |
| Sukumar Nagendran | 15 |
| Kazuaki Kama | 15 |
| Antoine Yver | 10 |
| Kunio Ishihara | 10 |
| Takashi Okimoto | 10 |
| Hiroshi Hirabayashi | 10 |
| Jay Feingold | 8 |
| Tsuguya Fukui | 7 |
| Francis Plat | 6 |
| Takaaki Nishii | 6 |
| Susan Romanus | 6 |
| Yoshifumi Nishikawa | 6 |
| Takashi Shoda | 6 |
| Noritaka Uji | 6 |
- Bourse
- Insiders
- Takashi Matsumoto
- Connexions Sociétés
